Financial reports
ARS
2023 FY
Annual report to shareholders
14 Jun 24
10-Q
2024 Q1
Quarterly report
9 May 24
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
20 Jul 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
29 Mar 23
Current reports
8-K
Regulation FD Disclosure
4 Jun 24
8-K
Entry into a Material Definitive Agreement
24 May 24
8-K
Regulation FD Disclosure
9 Apr 24
8-K
Regulation FD Disclosure
5 Feb 24
8-K
Results of Operations and Financial Condition
2 Feb 24
8-K
Regulation FD Disclosure
12 Dec 23
8-K
Departure of Directors or Certain Officers
24 Nov 23
8-K
Regulation FD Disclosure
10 Oct 23
8-K
Departure of Directors or Certain Officers
14 Sep 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
24 May 24
424B5
Prospectus supplement for primary offering
23 May 24
S-8
Registration of securities for employees
29 Mar 24
S-3
Shelf registration
2 Feb 24
S-8
Registration of securities for employees
15 Nov 23
D
$18.00 mm in equity, sold $5.50 mm, 19 investors
28 Jun 23
S-1
IPO registration
27 Jun 23
D
$33.30 mm in equity, sold $18.30 mm, 69 investors
15 Jun 23
S-8
Registration of securities for employees
26 Jan 23
424B4
Prospectus supplement with pricing info
26 Jan 23
Other
EFFECT
Notice of effectiveness
14 Feb 24
UPLOAD
Letter from SEC
8 Feb 24
CORRESP
Correspondence with SEC
8 Feb 24
EFFECT
Notice of effectiveness
5 Jul 23
CORRESP
Correspondence with SEC
29 Jun 23
UPLOAD
Letter from SEC
28 Jun 23
CERT
Certification of approval for exchange listing
26 Jan 23
EFFECT
Notice of effectiveness
26 Jan 23
SEC STAFF
SEC staff action: Order
26 Jan 23
CORRESP
Correspondence with SEC
23 Jan 23